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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1401Echocardiographic Assessment of Myocardial StrainJohn Gorcsan III, Hidekazu Tanaka
Echocardiographic strain imaging, also known as deformation imaging, provides a method
for objectively quantifying myocardial mechanical function. Gorcsan and Tanaka review the
utility of strain imaging for identifying cardiac ischemia and infarction (primary diseases of
the myocardium), assessment of dyssynchrony for cardiac resynchronization therapy, the
effects of valvular disease on myocardial function, and the mechanics of diastolic function.
Strain imaging is now an established and robust research tool that is likely to play a greater
role in the clinical care of future cardiovascular patients.CLINICAL RESEARCH CLINICAL TRIAL1414CCTA Faster Than MPI for Diagnosis of Chest Pain in the EDJames A. Goldstein, Kavitha M. Chinnaiyan, Aiden Abidov, Stephan Achenbach, Daniel S. Berman,
Sean W. Hayes, Udo Hoffmann, John R. Lesser, Issam A. Mikati, Brian O’Neil, Leslee J. Shaw,
Michael Y. H. Shen, Uma S. Valeti, Gilbert L. Raff, for the CT-STAT Investigators
Goldstein and colleagues compared the efficiency, emergency department (ED) costs, and
safety of a diagnostic strategy employing early coronary computed tomographic angiography
(CCTA) compared with rest-stress myocardial perfusion imaging (MPI) in a multicenter
trial. CCTA resulted in a 54% reduction in time-to-diagnosis compared with MPI (median
2.9 h vs. 6.2 h) and a 38% reduction in ED costs-of-care. The 6-month incidence of major
adverse cardiovascular events was similar after normal index testing. In acute, low-risk chest
pain patients, CCTA was a safe initial noninvasive test that resulted in a more rapid diagnosis
and reduced ED costs compared with rest-stress MPI.
Editorial Comment: Michael Salerno, Jamieson M. Bourque, George A. Beller, p. 1423(continued on page A-20)
SEPTEMBER 27, 2011 (continued) A-20INTERVENTIONAL CARDIOLOGY1426Meta-Analysis Compares PCI With CABG for Left Main DiseaseDavide Capodanno, Gregg W. Stone, Marie C. Morice, Theodore A. Bass, Corrado Tamburino
Previous meta-analyses of percutaneous coronary intervention (PCI) compared with coronary
artery bypass grafting (CABG) for left main stenoses mainly included nonprospective,
observational studies. Several trials with randomized patient allocations have recently been
published, prompting Capodanno and colleagues to perform a new meta-analysis. The
primary endpoint was the 1-year incidence of major adverse cardiac and cerebrovascular events
(MACCE). There was no significant difference in MACCE or the individual endpoints of
death and myocardial infarction. PCI was associated with higher rates of target vessel
revascularization (11.4% vs. 5.4%), but a reduced risk of stroke (0.1% vs. 1.7%). The authors
believe that, based on these results, revision of the guidelines regarding left main PCI is
warranted, raising the Level of Evidence of current recommendations from B to A.CARDIOVASCULAR RISK1433Vitamin D Deficiency Associated With Increased Cardiovascular RiskBryan Kestenbaum, Ronit Katz, Ian de Boer, Andy Hoofnagle, Mark J. Sarnak, Michael G. Shlipak,
Nancy S. Jenny, David S. Siscovick
Lower serum 25-hydroxyvitamin D (25-OHD) concentrations represent decreased vitamin D
stores, whereas serum parathyroid hormone (PTH) excess reflects, in part, inadequate
biological vitamin D activity. Based on these relationships, Kestenbaum and colleagues
evaluated the links between 25-OHD and PTH concentrations, both separately and in
combination, with incident cardiovascular events and mortality during long-term follow-up. A
total of 17% of subjects had low serum 25-OHD concentrations and were at a 29% greater
risk of mortality. The 25% of subjects with elevated serum PTH had a 30% greater risk of
heart failure, but not other outcomes. There was no evidence of an interaction between serum
25-OHD and PTH concentrations and cardiovascular events. These results suggest that
vitamin D and PTH might influence cardiovascular risk through divergent pathways.
Editorial Comment: Carlos A. Camargo, Jr, p. 1442(continued on page A-24)
SEPTEMBER 27, 2011 (continued) A-24ANTIPLATELET THERAPY1445Diagnosis and Treatment for Clopidogrel Hypersensitivity ReactionsAsim N. Cheema, Atif Mohammad, Tony Hong, Henry R. Jakubovic, Gurpreet S. Parmar, Waseem Sharieff,
M. Bernadette Garvey, Michael J. B. Kutryk, Neil P. Fam, John J. Graham, Robert J. Chisholm
Hypersensitivity reactions to clopidogrel create clinical uncertainty. Cheema and colleagues
describe 62 patients, representing 1.6% of their percutaneous coronary intervention
population, who developed clopidogrel hypersensitivity. The main findings of the study are:
1) clopidogrel hypersensitivity is characterized by a generalized exanthematous rash, which
affects trunk and proximal extremities and occurs at a median of 5 days after initiation;
2) clopidogrel hypersensitivity is a lymphocyte-mediated delayed hypersensitivity response in
patients with cutaneous manifestations and an immediate hypersensitivity reaction in patients
with angioedema or urticaria; 3) clopidogrel hypersensitivity can be successfully treated with a
short course of oral steroids without discontinuing clopidogrel; and 4) a total of 40% of
patients with an allergic cutaneous response to clopidogrel have cross-reactivity with
ticlopidine or prasugrel.Editorial Comment: Paul A. Gurbel, Young-Hoon Jeong, Udaya S. Tantry, p. 1455HEART FAILURE1457Lower Income Associated With Higher Incidence of HF HospitalizationRashmee U. Shah, Marilyn A. Winkleby, Linda Van Horn, Lawrence S. Phillips, Charles B. Eaton,
Lisa W. Martin, Milagros C. Rosal, JoAnn E. Manson, Hongyan Ning, Donald M. Lloyd-Jones, Liviu Klein
Shah and colleagues used data from the Women’s Health Initiative hormone trials to examine
the association between socioeconomic status and incident heart failure (HF) hospitalization.
Women with household incomes $20,000/year were 3 times more likely to have a first
hospitalization for HF compared with women with household incomes $50,000/year; the
risk ratio dropped to 1.6 after multivariable adjustment. Lower income is associated with an
increased incidence of HF hospitalization among healthy, post-menopausal women, even after
controlling for known risk factors.HEART FAILURE1465Quality of Care May Be Affected by a Patient’s Health Insurance StatusJohn R. Kapoor, Roger Kapoor, Anne S. Hellkamp, Adrian F. Hernandez, Paul A. Heidenreich,
Gregg C. Fonarow
Kapoor and colleagues used data from a large registry of nearly 100,000 heart failure (HF)
hospitalizations to analyze the relationship between payment source and quality of care.
Patients were grouped based on payer status (private/health maintenance organization, no
insurance, Medicare, and Medicaid). The no-insurance group was less likely to receive
evidence-based beta-blockers (EBBB), an implantable cardioverter-defibrillator (ICD), and
anticoagulation for atrial fibrillation. Similarly, the Medicaid group was less likely to receive
EBBB or ICDs. Higher mortality rates were observed in the Medicaid and no-insurance
groups. Decreased quality of care and worse outcomes for patients with HF may be linked to
health insurance coverage.Editorial Comment: Marvin A. Konstam, p. 1472
(continued on page A-25)
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Zachary M. Gertz, Amresh Raina, Laszlo Saghy, Erica S. Zado, David J. Callans, Francis E. Marchlinski,
Martin G. Keane, Frank E. Silvestry
Gertz and colleagues sought to determine whether atrial fibrillation (AF) causes mitral
regurgitation (MR), and if this MR would improve after restoration of sinus rhythm. Patients
with at least moderate MR with structurally normal valve leaflets undergoing a first AF
ablation were followed for 1 year. On follow-up echocardiogram, patients in continuous sinus
rhythm had greater reductions in left atrial size and annular dimension, and had lower rates
of significant MR (24% vs. 82%) compared with those in whom sinus rhythm was not
restored. These findings suggest that AF can result in transient MR, which the authors
classify as atrial functional MR.Editorial Comment: Brian D. Hoit, p. 1482HEART RHYTHM DISORDERS1485Predictors of Appropriate ICD Therapy in Patients With ARVD/CAditya Bhonsale, Cynthia A. James, Crystal Tichnell, Brittney Murray, Dmitri Gagarin, Binu Philips,
Darshan Dalal, Ryan Tedford, Stuart D. Russell, Theodore Abraham, Harikrishna Tandri, Daniel P. Judge,
Hugh Calkins
Bhonsale and colleagues reviewed data from 84 patients with arrhythmogenic right ventricular
dysplasia/cardiomyopathy (ARVD/C) to define the incidence and predictors of implantable
cardioverter-defibrillator (ICD) therapy in patients who received a device for primary
prevention. Over a mean follow-up of 4.7 years, appropriate ICD therapy occurred in 48% of
patients. Factors associated with increased risk included proband status, inducibility at
electrophysiological study, presence of nonsustained ventricular tachycardia, and Holter
premature ventricular contraction count 1,000/24 h. Nearly one-half of the ARVD/C
patients with primary prevention ICD implantation experienced appropriate ICD
interventions during follow-up, and these results will help to identify those patients at highest
risk for fatal arrhythmias.(continued on page A-26)
SEPTEMBER 27, 2011 (continued) A-26BIOMARKERS1497NT-proBNP Superior to LVEF for Predicting Risk of Heart FailureChristopher R. deFilippi, Robert H. Christenson, Willem J. Kop, John S. Gottdiener, Min Zhan,
Stephen L. Seliger
deFilippi and colleagues measured left ventricular ejection fraction (LVEF) and N-terminal
pro–B-type natriuretic peptide (NT-proBNP) to determine which was superior for the
prediction of new onset heart failure (HF) and cardiovascular mortality in older adults. Repeat
measures of NT-proBNP were performed 2 to 3 years later, and echocardiography was
repeated 5 years later. For participants with a low baseline NT-proBNP level (190 pg/ml),
the addition of an abnormal LVEF did not improve the estimation of risk of HF and
provided only a moderate increase in adjusted risk for cardiovascular mortality. Participants
with an initially high NT-proBNP were at greater risk for both outcomes, particularly those
patients with an abnormal LVEF.Editorial Comment: A. Mark Richards, p. 1507CONGENITAL HEART DISEASE1509Prevalence of Congenital Heart Disease in Geriatric PatientsJonathan Afilalo, Judith Therrien, Louise Pilote, Raluca Ionescu-Ittu, Giuseppe Martucci, Ariane J. Marelli
Afilalo and colleagues sought to examine the prevalence, disease burden, and determinants of
mortality in congenital heart disease (CHD) patients older than 65 years of age living in
Quebec, Canada. The geriatric CHD cohort consisted of 3,239 patients. The most common
types of CHD lesions in older adults were shunt lesions (60%), followed by valvular lesions
(37%) and severe congenital heart lesions (3%). The type of CHD and CHD-related
complications had a minor impact on mortality, which was predominantly driven by acquired
comorbid conditions typical in geriatric patients. The prevalence of geriatric CHD is
substantial, but these results suggest that CHD patients are living long enough to acquire
age-related medical comorbidities that are the pre-eminent determinants of their mortality.
